vimarsana.com
Home
Live Updates
FDA On Use Of AI/ML In Drug Development: Five Key Takeaways
FDA On Use Of AI/ML In Drug Development: Five Key Takeaways
FDA On Use Of AI/ML In Drug Development: Five Key Takeaways | MoFo Life Sciences
On Wednesday, May 10, 2023, the Food and Drug Administration (FDA) announced the publication of a new discussion paper titled “Using Artificial Intelligence and Machine Learning in the...
Related Keywords
United Kingdom ,
Canada ,
,
Cder Ai Steering Committee ,
National Evaluation System ,
Regulatory Agency ,
Drug Development ,
Technology Approaches For New Drugs ,
Development Of Standards ,
Drug Administration ,
Health Canada ,
Pilot Program ,
National Institute For Standards ,
Model Development ,
Development Of Drug ,
Mofo Life Sciences ,
Mofo Life ,
Artificial Intelligence ,
Machine Learning ,
Biological Products ,
Beach Stage ,
Growing Its Own Experience ,
Innovative Science ,
Technology Approaches ,
New Drugs ,
Informed Drug Development ,
Evaluation System ,
National Institute ,
Federal Engagement ,
Developing Technical Standards ,
Related Tools ,
Good Machine Learning Practices ,
Identified Key Questions ,
Led Governance ,